Table 3. .
Method | Required knowledge# |
---|---|
Blinded search or screening method |
Off-label use Phenotypic screening |
Target-based methods | Phenotypic screening; Target 3D structure, chemical structure information of drugs and ligands |
Knowledge-based methods |
Drug–target information, chemical structure information of targets and adverse effects (clinical trial information) Regulatory approval labels and adverse effects Available pathway information of disease |
Signature-based methods |
Disease omics data; Genetics data; Drug omics data Disease omics and drug omics data |
Pathway- or network-based methods | Disease omics data, available pathway information, and protein interaction network; Drug omics data |
Targeted mechanism-based methods | Drug omics data, disease pathway and protein interaction network |
# Repurposing methods require various skills and knowledge of various factors, that is, it may be drug-oriented or disease-oriented, or treatment-oriented [4]